SK biopharmaceuticals
Developing innovative and next-generation drugs for central nervous system.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD1.1—1.7b (Dealroom.co estimates Nov 2021.)
Seongnam-si Gyeonggi-do (HQ)
Authorizing premium user...